CERTAINTY 2025: The power of Model-Informed Drug Development Blog CERTAINTY 2025: The power of Model-Informed Drug Development We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…CertaraMay 16, 2025
Machine Learning for PK/PD Modeling in Drug Development Blog Machine Learning for PK/PD Modeling in Drug Development Pharmacometricians can use machine learning for PK/PD modeling to help them characterize the safety and…CertaraMarch 4, 2025
Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters Blog Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters January 10, 2025 Friedreich’s Ataxia (FA) is a rare, genetic, and progressive neurodegenerative disorder. A…CertaraJanuary 10, 2025
Shining a spotlight on Clinical Study Software at the 2024 Pinnacle 21 Enterprise User Group Meeting Blog Shining a spotlight on Clinical Study Software at the 2024 Pinnacle 21 Enterprise User Group Meeting On October 30, 2024, we hosted our Pinnacle 21 Enterprise (P21E) User Group Meeting (UGM)…CertaraNovember 12, 2024
Don’t Miss Our Inaugural Event for Biosimulation Users Blog Don’t Miss Our Inaugural Event for Biosimulation Users Join us for an in-person event where you can learn from drug development experts, network…CertaraMarch 26, 2024
How Biosimulation & AI Tech Could Solve Pharma’s R&D Productivity Crisis Blog How Biosimulation & AI Tech Could Solve Pharma’s R&D Productivity Crisis Drug development continues to be painfully slow and mind-bogglingly expensive. In a 2010 article, Stephen…CertaraOctober 27, 2023